De Burlo Group Inc Gilead Sciences, Inc. Transaction History

De Burlo Group Inc

$736 Million
Q1 2024

A detailed history of De Burlo Group Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, De Burlo Group Inc holds 8,598 shares of GILD stock, worth $623,870. This represents 0.09% of its overall portfolio holdings.

Number of Shares

8,598

Previous 9,698 11.34%

Holding current value

$623,870

Previous $785,000 19.87%

% of portfolio

0.09%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $78,738 - $96,019	-1,100 Reduced 11.34%	8,598 $629,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $7,394 - $8,067	-100 Reduced 1.02%	9,698 $726,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $37,392 - $53,682	600 Added 6.52%	9,798 $841,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $547,648 - $625,555	9,198 New	9,198 $567,000
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $541,471 - $609,858	-9,381 Closed	0 $0

Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $28,960 - $36,290	-500 Reduced 5.06%	9,381 $557,000
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $2,301 - $2,483	-34 Reduced 0.34%	9,881 $690,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $45,320 - $51,640	800 Added 8.78%	9,915 $578,000
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $6,210 - $7,808	-100 Reduced 1.09%	9,115 $576,000
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $317,847 - $407,116	-5,075 Reduced 35.51%	9,215 $689,000
Q4 2019 Feb 06, 2020	SELL	$61.62 - $67.78 $61,620 - $67,780	-1,000 Reduced 6.54%	14,290 $928,000
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $68,761 - $75,900	-1,100 Reduced 6.71%	15,290 $969,000
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $55,683 - $62,441	-900 Reduced 5.21%	16,390 $1.11 Million
Q1 2019 May 09, 2019	SELL	$62.53 - $70.05 $462,722 - $518,370	-7,400 Reduced 29.97%	17,290 $1.12 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $41,469 - $54,115	-685 Reduced 2.7%	24,690 $1.54 Million
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $64,152 - $71,028	-900 Reduced 3.43%	25,375 $1.96 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $58,391 - $68,112	-900 Reduced 3.31%	26,275 $1.86 Million
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $254,940 - $310,800	-3,500 Reduced 11.41%	27,175 $2.05 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $56,920 - $66,816	-800 Reduced 2.54%	30,675 $2.2 Million
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $2.27 Million - $2.69 Million	31,475	31,475 $2.55 Million

Others Institutions Holding GILD

# of Institutions

1,892

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $90.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.

Account

De Burlo Group Inc Gilead Sciences, Inc. Transaction History